LeonaBio, Inc. (LONA) stock
LONANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$2.46−0.19 (-7.17%)
Close on Nov 19, 2026Market cap $23.18MP/E –Yield –
LeonaBio total assets
Total assets on the balance sheet at the end of each period.
LeonaBio's total assets was $56.89M at Jun 30, 2026. For fiscal 2025 it was $92.15M, up 56.8% from the year before. The highest annual figure on record is $332.01M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $92.15M | +56.8% |
| FY2024 | Dec 31, 2024 | $58.78M | -63.3% |
| FY2023 | Dec 31, 2023 | $160.25M | -37.9% |
| FY2022 | Dec 31, 2022 | $258.15M | -22.2% |
| FY2021 | Dec 31, 2021 | $332.01M | +18.8% |
| FY2020 | Dec 31, 2020 | $279.56M | +12671.3% |
| FY2019 | Dec 31, 2019 | $2.19M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $56.89M | +60.1% |
| Q1 FY2026 | Mar 31, 2026 | $71.59M | +64.5% |
| Q4 FY2025 | Dec 31, 2025 | $92.15M | +56.8% |
| Q3 FY2025 | Sep 30, 2025 | $30.03M | -65.2% |
| Q2 FY2025 | Jun 30, 2025 | $35.55M | -68.1% |
| Q1 FY2025 | Mar 31, 2025 | $43.51M | -67.4% |
| Q4 FY2024 | Dec 31, 2024 | $58.78M | -63.3% |
| Q3 FY2024 | Sep 30, 2024 | $86.25M | -53.3% |
| Q2 FY2024 | Jun 30, 2024 | $111.25M | -46.5% |
| Q1 FY2024 | Mar 31, 2024 | $133.46M | -42.7% |
| Q4 FY2023 | Dec 31, 2023 | $160.25M | -37.9% |
| Q3 FY2023 | Sep 30, 2023 | $184.70M | -32.6% |
| Q2 FY2023 | Jun 30, 2023 | $208.05M | -28.8% |
| Q1 FY2023 | Mar 31, 2023 | $232.77M | -25.6% |
| Q4 FY2022 | Dec 31, 2022 | $258.15M | -22.2% |
| Q3 FY2022 | Sep 30, 2022 | $274.19M | -21.1% |
| Q2 FY2022 | Jun 30, 2022 | $292.01M | -18.9% |
| Q1 FY2022 | Mar 31, 2022 | $313.00M | -15.3% |
| Q4 FY2021 | Dec 31, 2021 | $332.01M | +18.8% |
| Q3 FY2021 | Sep 30, 2021 | $347.33M | +29.6% |
| Q2 FY2021 | Jun 30, 2021 | $360.12M | +16351.5% |
| Q1 FY2021 | Mar 31, 2021 | $369.41M | – |
| Q4 FY2020 | Dec 31, 2020 | $279.56M | – |
| Q3 FY2020 | Sep 30, 2020 | $267.94M | – |
| Q4 FY2019 | Dec 31, 2019 | $2.19M | – |
See a number that looks wrong?